Teladoc Health, Inc. (NYSE:TDOC) Given Average Rating of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has been assigned an average recommendation of “Hold” from the sixteen research firms that are currently covering the firm, MarketBeat reports. Ten equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $19.67.

TDOC has been the subject of a number of research reports. Cantor Fitzgerald initiated coverage on shares of Teladoc Health in a report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 target price for the company. Royal Bank of Canada reduced their target price on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a report on Friday. TD Cowen reduced their target price on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a report on Friday. Stifel Nicolaus reduced their target price on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a report on Friday. Finally, Leerink Partnrs reissued a “market perform” rating on shares of Teladoc Health in a report on Monday, February 26th.

Insider Buying and Selling at Teladoc Health

In other news, EVP Andrew Turitz sold 6,190 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $89,878.80. Following the completion of the transaction, the executive vice president now directly owns 39,429 shares of the company’s stock, valued at approximately $572,509.08. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Andrew Turitz sold 6,190 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The disclosure for this sale can be found here. Over the last three months, insiders sold 135,441 shares of company stock valued at $2,038,251. Corporate insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of the company. Lecap Asset Management Ltd. acquired a new position in Teladoc Health in the fourth quarter valued at $1,530,000. Sowell Financial Services LLC increased its stake in shares of Teladoc Health by 40.8% during the 4th quarter. Sowell Financial Services LLC now owns 18,907 shares of the health services provider’s stock valued at $407,000 after acquiring an additional 5,475 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of Teladoc Health by 12.4% during the 3rd quarter. Deutsche Bank AG now owns 301,147 shares of the health services provider’s stock worth $5,598,000 after acquiring an additional 33,287 shares during the period. Sherbrooke Park Advisers LLC acquired a new stake in shares of Teladoc Health in the third quarter worth approximately $680,000. Finally, QRG Capital Management Inc. purchased a new stake in Teladoc Health in the third quarter valued at approximately $392,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Stock Performance

NYSE TDOC opened at $13.01 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47. Teladoc Health has a 1 year low of $12.65 and a 1 year high of $30.41. The company has a market capitalization of $2.20 billion, a PE ratio of -9.71 and a beta of 0.94. The company has a fifty day moving average of $15.01 and a two-hundred day moving average of $17.77.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same quarter in the prior year, the company earned ($0.37) EPS. The business’s revenue was up 2.7% on a year-over-year basis. As a group, analysts expect that Teladoc Health will post -1.07 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.